Hospital.Help

Foster City The capsid inhibitor lenacapavir, which only needs to be injected subcutaneously every six months, could make HIV pre-exposure prophylaxis easier. After the manufacturer recently presented initial results from the PURPOSE-1 study on protecting young women from infection through vaginal sex, interim results from PURPOSE-1 on people who are at risk from receptive anal sex are now available. In the study…